Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Profound Medical (PROF)
:PROF
RESEARCH TOOLSreports
Holding PROF?
Track your performance easily
PROF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.78 - $11.42
Previous CloseN/A
Volume13.91K
Average Volume (3M)104.32K
Market Cap
$219.16M
Enterprise Value$235.77M
Total Cash (Recent Filing)$1.47M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.34
Next Earnings
Mar 11, 2025EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding30,028,477
10 Day Avg. Volume61,521
30 Day Avg. Volume104,322
Standard Deviation0.25
R-Squared0.03
Alpha0.00828
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)22.23
Price to Cash Flow (P/CF)-7.90
P/FCF Ratio0.00
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue26.24
Enterprise Value/Gross Profit53.80
Enterprise Value/Ebitda-8.02
Forecast
1Y Price Target
$22.20Price Target Upside202.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Profound Medical (US) News
PremiumCompany Announcements
Profound Medical Reports Robust Revenue Growth and Transition to U.S. GAAP
PremiumCompany Announcements
Profound Medical to Present at J.P. Morgan Healthcare Conference
Options Prices
Currently, No data available
---
Ownership Overview
18.59% Insiders
1.49% Mutual Funds
23.10% Other Institutional Investors
56.76% Public Companies and
Individual Investors
PROF FAQ
What was Profound Medical’s price range in the past 12 months?
Profound Medical lowest stock price was $6.78 and its highest was $11.42 in the past 12 months.
What is Profound Medical’s market cap?
Profound Medical’s market cap is $219.16M.
When is Profound Medical’s upcoming earnings report date?
Profound Medical’s upcoming earnings report date is Mar 11, 2025 which is in 49 days.
How were Profound Medical’s earnings last quarter?
Profound Medical released its earnings results on Nov 07, 2024. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of -$0.3 by -$0.08.
Is Profound Medical overvalued?
According to Wall Street analysts Profound Medical’s price is currently Undervalued.
Does Profound Medical pay dividends?
Profound Medical does not currently pay dividends.
What is Profound Medical’s EPS estimate?
Profound Medical’s EPS estimate is -0.34.
How many shares outstanding does Profound Medical have?
Profound Medical has 30,028,477 shares outstanding.
What happened to Profound Medical’s price movement after its last earnings report?
Profound Medical reported an EPS of -$0.38 in its last earnings report, missing expectations of -$0.3. Following the earnings report the stock price went down -2.344%.
Which hedge fund is a major shareholder of Profound Medical?
Currently, no hedge funds are holding shares in PROF
---
Profound Medical (US) Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.20 (202.04% Upside)
$22.20 (202.04% Upside)
Blogger Sentiment
Bullish
PROF Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth C$361.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.49%
12-Months-Change
Fundamentals
Return on Equity
-90.83%
Trailing 12-Months
Asset Growth
-16.34%
Trailing 12-Months
Company Description
Profound Medical
Profound Medical Corp is a medical technology company. It provides incision-free therapies that combine real-time Magnetic Resonance (MR) imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The company develops a treatment to ablate the prostate gland in prostate cancer patients.
---
PROF Stock 12 Month Forecast
Average Price Target
$22.20
▲(202.04% Upside)
Technical Analysis
Profound Medical
―
HLS Therapeutics Inc
―
MedX Health
―
Reliq Health Technologies
―
Medmira
―
Ondine Biomedical, Inc.
―
Best Analysts Covering PROF
1 Year
1 Year Success Rate
4/14 ratings generated profit
1 Year Average Return
-1.53%
assigned a buy rating 11 days ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -1.53% per trade.
---